DA calls for investigation into anti-competitive conduct at Aspen

Organisation: Position: Deadline Date: Location:

The Competition Commission is to conduct an investigation into the alleged anti-competitive conduct of Aspen Pharmacare, reports News24. “It is important that any possible anti-competitive behaviour, which would push up the price of medication for our people, must be fully investigated,” said DA MP Wilmot James.

The report says Aspen shares dropped after UK reports claimed it had secretly planned to destroy life-saving cancer medicines, as a threat to force countries in Europe to allow price hikes. The company is already in an ongoing legal process with European regulators, as well as a court in Italy. “The DA is concerned that the same practices may have been employed here in South Africa.”

Comment from the Competition Commission was not immediately available, the report said.

News24 report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.